<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_pmNYUKP">Behavioral Interventions to Improve Breast Cancer Screening Outreach Two Randomized Clinical Trials</title>
				<funder>
					<orgName type="full">University of Pennsylvania Health System</orgName>
					<orgName type="abbreviated">UPHS</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100016783</idno>
				</funder>
				<funder ref="#_K3VwsW8">
					<orgName type="full">Abramson Cancer Center</orgName>
					<orgName type="abbreviated">ACC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100017006</idno>
				</funder>
				<funder>
					<orgName type="full">Marc J. Leder Cancer Innovation Fund</orgName>
				</funder>
				<funder>
					<orgName type="full">National Cancer Institute of the National Institutes of Health</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2024 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/28/2025 © 2024 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by University of Iowa user on 07/28/2025 Conflict of Interest Disclosures: Dr Mehta reported receiving personal fees from Guardant Health and the American Gastroenterological Association outside the submitted</p>
				</availability>
				<date type="published" when="2024-05-06">May 6, 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD, MBA, MSHP</roleName><forename type="first">Shivan</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Corinne</forename><surname>Rhodes</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kristin</forename><forename type="middle">A</forename><surname>Linn</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Catherine</forename><surname>Reitz</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Caitlin</forename><surname>Mcdonald</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Evelyn</forename><surname>Okorie</surname></persName>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Keyirah</forename><surname>Williams</surname></persName>
						</author>
						<author>
							<persName><roleName>MSEd, MPH</roleName><forename type="first">David</forename><surname>Resnick</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Annamaria</forename><surname>Arostegui</surname></persName>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Timothy</forename><surname>Mcauliffe</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Colin</forename><surname>Wollack</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Christopher</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, MSIS</roleName><forename type="first">Maryanne</forename><forename type="middle">K</forename><surname>Peifer</surname></persName>
						</author>
						<author>
							<persName><roleName>MD IMPORTANCE</roleName><forename type="first">Susan</forename><forename type="middle">P</forename><surname>Weinstein</surname></persName>
						</author>
						<author>
							<persName><roleName>Reitz, McDonald, Okorie</roleName><surname>Mehta</surname></persName>
						</author>
						<author>
							<persName><surname>Rhodes</surname></persName>
						</author>
						<author>
							<persName><roleName>Reitz, McDonald, Okorie, Williams</roleName><surname>Linn</surname></persName>
						</author>
						<author>
							<persName><surname>Arostegui</surname></persName>
						</author>
						<author>
							<persName><roleName>Peifer</roleName><forename type="first">Weinstein</forename><surname>Mcauliffe</surname></persName>
						</author>
						<author>
							<persName><surname>Williams</surname></persName>
						</author>
						<author>
							<persName><roleName>McAuliffe, Snider);</roleName><surname>Resnick</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Perelman School of Medicine , University of Pennsylvania , Philadelphia</note>
								<orgName type="department">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Center for Health Care Innovation , University of Pennsylvania , Philadelphia</note>
								<orgName type="department">Center for Health Care Innovation</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Penn Medicine , University of Pennsylvania , Philadelphia (Rhodes , Wollack , Peifer).</note>
								<orgName type="department">Penn Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia (Rhodes Wollack</settlement>
									<region>Peifer</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Perelman School of Medicine , University of Pennsylvania , 3600 Civic Center Blvd , 8W-206 , Philadelphia , PA 19104</note>
								<orgName type="department">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<addrLine>3600 Civic Center Blvd 8W-206</addrLine>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_ZVbGtZb">Behavioral Interventions to Improve Breast Cancer Screening Outreach Two Randomized Clinical Trials</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2024-05-06">May 6, 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">B1E43114977952E4FBB3A0C1B84F6DAE</idno>
					<idno type="DOI">10.1001/jamainternmed.2024.0495</idno>
					<note type="submission">Accepted for Publication: February 2, 2024.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:53+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_Supg6qj">Reitz</term>
					<term xml:id="_4BUWK9Y">McDonald</term>
					<term xml:id="_x7XHmsq">Arostegui</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_XYhPgX9"><p xml:id="_ZF4As4v"><s xml:id="_aryE3KY">Despite public health efforts, breast cancer screening rates remain below national goals.</s></p><p xml:id="_DxxHVWw"><s xml:id="_Q5pTqv2">OBJECTIVE To evaluate whether bulk ordering, text messaging, and clinician endorsement increase breast cancer screening rates.</s></p><p xml:id="_3apmW2r"><s xml:id="_F78MzcC">DESIGN, SETTING, AND PARTICIPANTS Two concurrent, pragmatic, randomized clinical trials, each with a 2-by-2 factorial design, were conducted between October 25, 2021, and April 25, 2022, in 2 primary care regions of an academic health system.</s><s xml:id="_xx7mAKD">The trials included women aged 40 to 74 years with at least 1 primary care visit in the past 2 years who were eligible for breast cancer screening.</s></p><p xml:id="_ZFtTc9B"><s xml:id="_awCDbC2">INTERVENTIONS Patients in trial A were randomized in a 1:1 ratio to receive a signed bulk order for mammogram or no order; in a factorial design, patients were concurrently randomized in a 1:1 ratio to receive or not receive text message reminders.</s><s xml:id="_zdD9cEa">Patients in trial B were randomized in a 1:1 ratio to receive a message signed by their primary care clinician (clinician endorsement) or from the organization (standard messaging); in a factorial design, patients were concurrently randomized in a 1:1 ratio to receive or not receive text message reminders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GDBAghJ">MAIN OUTCOMES AND MEASURES</head><p xml:id="_w5qBDPP"><s xml:id="_ghCZerp">The primary outcome was the proportion of patients who completed a screening mammogram within 3 months.</s><s xml:id="_buzQKVq">RESULTS Among 24 632 patients included, the mean (SD) age was 60.4 (7.5) years.</s><s xml:id="_6jeGe5p">In trial A, at 3 months, 15.4% (95% CI, 14.6%-16.1%) of patients in the bulk order arm and 12.7% (95% CI, 12.1%-13.4%)</s><s xml:id="_bA5kh9m">in the no order arm completed a mammogram, showing a significant increase (absolute difference, 2.7%; 95% CI, 1.6%-3.6%;</s><s xml:id="_KPaGNZ4">P &lt; .001).</s><s xml:id="_45EbZC8">In the text messaging comparison arms, 15.1% (95% CI, 14.3%-15.8%) of patients receiving a text message completed a mammogram compared with 13.0% (95% CI, 12.4%-13.7%) of those in the no text messaging arm, a significant increase (absolute difference of 2.1%; 95% CI, 1.0%-3.0%;</s><s xml:id="_GZXw8kx">P &lt; .001).</s><s xml:id="_dzNMPzk">In trial B, at 3 months, 12.5% (95% CI, 11.3%-13.7%) of patients in the clinician endorsement arm completed a mammogram compared with 11.4% (95% CI, 10.3%-12.5%) of those in the standard messaging arm, which was not significant (absolute difference, 1.1%; 95% CI, -0.5% to 2.7%; P = .18).</s><s xml:id="_VAk9VVY">In the text messaging comparison arms, 13.2% (95% CI, 12.0%-14.4%) of patients receiving a text message completed a mammogram compared with 10.7% (95% CI, 9.7%-11.8%) of those in the no text messaging arm, a significant increase (absolute difference, 2.5%; 95% CI, 0.8%-4.0%;</s><s xml:id="_ECdTf6E">P = .003).</s></p><p xml:id="_BbArqXY"><s xml:id="_7d6D38s">CONCLUSIONS AND RELEVANCE These findings show that text messaging women after initial breast cancer screening outreach via either electronic portal or mailings, as well as bulk ordering with or without text messaging, can increase mammogram completion rates.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VvA8RPY">B</head><p xml:id="_Bc6rSTZ"><s xml:id="_vNruPMX">reast cancer is a leading cause of cancer death among women, <ref type="bibr" target="#b0">1</ref> and screening mammography has been shown to reduce the burden of the disease. <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref></s><s xml:id="_GxDtF5C">3]<ref type="bibr" target="#b3">[4]</ref> National rates remain below Healthy People 2030 aspirational targets of 80.5%, with known disparities in outcomes, particularly among Black women. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b4">5</ref></s><s xml:id="_mVwmPED">Rates were affected by the COVID-19 pandemic due to the temporary pause of screening and reduction in in-person primary care visits. <ref type="bibr" target="#b5">6</ref></s><s xml:id="_9WuhY5g">opulation health approaches that involve direct outreach to patients have been shown to boost screening rates but are not widely used. <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref></s><s xml:id="_w9g5x2H">]<ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> New insights from the field of behavioral economics have shown that humans have systematic biases, <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> which can be leveraged to improve adherence.</s><s xml:id="_9CHrKJR">For example, optout framing can overcome status quo bias <ref type="bibr" target="#b12">13</ref> by making preventive health the default option for patients. <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref></s><s xml:id="_m64eAtF">5]<ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> Bulk ordering of screening tests can reduce effort by both the clinician to individually sign the order and patients to obtain an order. <ref type="bibr" target="#b17">18</ref></s><s xml:id="_ZXYkcbm">Social norms suggest that patients may have higher response when the outreach is signed by their primary care clinician. <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref></s><s xml:id="_ZPzbFYH">0]<ref type="bibr" target="#b20">[21]</ref> In partnership with clinical operations, we conducted 2 concurrent pragmatic clinical trials to evaluate the effectiveness of bulk ordering, text messaging, and clinician endorsement with direct outreach on screening mammography completion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HMtXE6w">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Ky26VyP">Study Design</head><p xml:id="_gbdqcU2"><s xml:id="_uRXQWSJ">This study consisted of 2 concurrent, pragmatic, randomized clinical trials in different regions of an academic health system.</s><s xml:id="_sQn8eAk">Trial A was a 2-by-2 factorial design that evaluated bulk ordering and text messaging compared with standard outreach.</s><s xml:id="_7NtZ4GC">Trial B was a 2-by-2 factorial design that evaluated outreach signed by the primary care clinician and text messaging compared with standard outreach.</s></p><p xml:id="_XPNBuKK"><s xml:id="_K3RQ7w3">The study was approved by the institutional review board of the University of Pennsylvania.</s><s xml:id="_8zfrqDw">A waiver of informed consent was obtained since the study posed minimal risk to patients and could not have been practically performed without the waiver. <ref type="bibr" target="#b21">22</ref></s><s xml:id="_MwH4TJ8">The protocol and statistical analysis plan are provided in Supplement 1 and registered at ClinicalTrials.gov</s><s xml:id="_UvNvqeW">(NCT05089903).</s><s xml:id="_2hD5JMD">This study followed the Consolidated Standards of Reporting Trials (CONSORT) guideline (Figures <ref type="figure" target="#fig_0">1</ref> and <ref type="figure" target="#fig_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Un29eCZ">Study Population</head><p xml:id="_5Aa2BWH"><s xml:id="_VmCFCyG">Using automated electronic health record (EHR) data extraction on October 19, 2021, we identified all women aged 50 to 74 years who were not up to date with screening for breast cancer according to the health maintenance section (default is biennial screening but can be modified by the clinician), as well as those aged 40 to 49 years whose status was modified as eligible based on shared decision-making with the patient and</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Dbee7nD">Key Points</head><p xml:id="_btMF6ag"><s xml:id="_qKEwPTE">Question Do behavioral interventions such as bulk ordering, text messaging, and clinician endorsement increase breast cancer screening response rates?</s><s xml:id="_juPm8cP">Findings In 2 randomized clinical trials of 24 632 patients, bulk ordering and text messaging significantly increased uptake of breast cancer screening.</s></p><p xml:id="_UFsvX8E"><s xml:id="_aqfPdEw">Meaning These findings demonstrate that behavioral nudges, such as opt-out framing, bulk ordering, and text messaging, can be included in population health outreach programs to increase breast cancer screening.</s><s xml:id="_A5Xv2tp">18 453 Eligible patients 18 453 Randomized patients 4614 No order 1 Excluded prior to outreach Current legal sex is not the same as sex assigned at birth 1 4613 Outreach 4612 No order + text 2 Excluded prior to outreach Current legal sex is not the same as sex assigned at birth 2 4610 Outreach 4613 Bulk order 3 Excluded prior to outreach Current legal sex is not the same as sex assigned at birth 3 4610 Outreach 2 Excluded prior to outreach 2 Current legal sex is not the same as sex assigned at birth 4614 Bulk order + text 4612 Outreach 4608 Total analyzed 4597 Total analyzed 4602 Total analyzed 4605 Total analyzed 5 Excluded after outreach Mastectomy 3 13 Excluded after outreach Mastectomy 2 8 Excluded after outreach Mastectomy 3 1 Mastectomy Died 2 Died 11 Died 5 6 Died 7 Excluded after outreach</s></p><p xml:id="_UcZ3hyR"><s xml:id="_tK879RM">clinician input in the EHR.</s><s xml:id="_dsQMyk4">All patients had at least 1 visit within the past 2 years with a system-based primary care clinician.</s><s xml:id="_5p3Huf5">Patients were excluded if they were currently scheduled for a mammogram, had a history of bilateral mastectomy, or were of current legal sex of male with sex of female assigned at birth.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2XaBpq6">Interventions</head><p xml:id="_HtxYetx"><s xml:id="_eyNKZWB">Trial A Eligible patients in region A were randomized by study staff in a 1:1 ratio stratified by patient portal status using a computergenerated randomization algorithm to no order (arms A1 and A2) or bulk order (arms A3 and A4).</s><s xml:id="_9kyzjGg">Patients in the no order arms received either a patient portal message or a mailed letter indicating that they were overdue for mammography screening, with instructions to request an order from their primary care clinician.</s><s xml:id="_BGjHkh3">Patients randomized to the bulk order arms received an order for a bilateral screening mammogram (with diagnostic mammogram and ultrasound as needed), with the patient's primary care clinician included as the accountable clinician to receive the results.</s><s xml:id="_4mmFpYQ">Orders were placed via a bulk ordering process by a designated practice physician based on region or department at the beginning of the trial.</s><s xml:id="_T3KfYbB">Electronic portal patients received a message and scheduling ticket through their portal, while letter patients received a printed order with the mailed letter.</s><s xml:id="_udJuhny">A follow-up message was sent to those who did not schedule or complete their mammogram 1 month after initial outreach in both arms via patient portal message or letter.</s><s xml:id="_x5bMPkS">In a 2-by-2 factorial design, patients were concurrently randomized in a 1:1 ratio to additionally receive or not receive text message reminders, resulting in arm A1, no order and no text message; arm A2, no order and text message; arm A3, bulk order and no text message; and arm A4, bulk order and text message.</s><s xml:id="_xhyVKpQ">Patients in the text messaging arms (A2 or A4) received a series of 3 text messages, including an anticipatory text message and reminders at 2 weeks and 2 months.</s><s xml:id="_eTPCjb8">Patients had the option to reply "Done" if they had already completed their mammogram elsewhere or "Support" if they had questions.</s><s xml:id="_ShC6Gda">Date and location information submitted about prior screening was forwarded to a population health coordinator for follow-up.</s><s xml:id="_W92krwr">Patient questions were manually reviewed and responded to by research staff (E.O. and A.A.) or routed to the clinician if necessary.</s><s xml:id="_SX5DNZR">Text messaging was conducted using Way to Health, a National Institutes of Health-funded software platform that facilitates and automates many aspects of study design and intervention implementation. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_B6UHhBq">Patients were excluded from reminder messaging if they were discovered to be currently in hospice, if they had metastatic cancer, or if another change in the health maintenance section of the EHR had occurred.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WyNh3kH">Trial B</head><p xml:id="_DTHwa7S"><s xml:id="_jVknMkd">Eligible patients in region B were stratified by patient portal status and randomized in a 1:1 ratio to receive either a portal message or letter signed by their primary care clinician (clinician endorsement, arms B1 and B2) or from the organization (standard messaging, arms B3 and B4).</s><s xml:id="_srPFd8N">As in trial A, a follow-up message was sent to those who did not schedule or complete their mammogram 1 month after initial outreach in both arms via patient portal message or letter.</s></p><p xml:id="_QZCefpr"><s xml:id="_FCyHJHy">In a 2-by-2 factorial design, patients in trial B were concurrently randomized in a 1:1 ratio to additionally receive or not receive text reminders, resulting in arm B1, clinician endorsement and no text message; arm B2, clinician endorsement and text message; arm B3, standard messaging and no text message; and arm B4, standard messaging and text message.</s><s xml:id="_6H93dX5">Patients in the text messaging arms (arms B2 and B4) received the same messaging as described earlier.</s></p><p xml:id="_8Q9kaYf"><s xml:id="_hcpfZsE">Outreach for both trials was conducted between October 25 and December 20, 2021.</s><s xml:id="_URbT9XG">The trial concluded on April 25, 6227 Eligible patients 6227 Randomized patients 1557 Clinician endorsement 2 Excluded prior to outreach Current legal sex is not the same as sex assigned at birth 2 1555 Outreach 1553 Total analyzed 2 Excluded after outreach 1556 Clinician endorsement + text 0 Excluded prior to outreach 1556 Outreach 1556 Total analyzed 0 Excluded after outreach 1557 Standard messaging 0 Excluded prior to outreach 1557 Outreach 1556 Total analyzed 1 Excluded after outreach Died 1 0 Excluded prior to outreach 1557 Standard messaging + text 1557 Outreach 1555 Total analyzed 2 Mastectomy 2 Excluded after outreach Died 2 Behavioral Interventions to Improve Breast Cancer Screening Outreach Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2024 Volume 184, Number 7 2022, 6 months from initial outreach.</s><s xml:id="_GnZUYve">All communication details are provided in Supplement 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UDkXWYU">Study Outcomes</head><p xml:id="_CAhpdSN"><s xml:id="_KcnzvHX">The primary outcome was completion of a screening mammogram within 3 months of initial outreach.</s><s xml:id="_jEKcPnT">Secondary outcomes were completion within 6 months and scheduling of the mammogram within 3 and 6 months.</s><s xml:id="_G2NSE3x">The proportion of mammograms that had positive results and subsequent care were also tracked.</s><s xml:id="_7mPErEa">Race and ethnicity were based on self-reported data in the EHR (Asian or Pacific Islander, Black, Hispanic or Latino, White, and other [including American Indian or Alaska Native and not reported] or unknown) and were analyzed to understand differential responses to interventions since there are known disparities in uptake and outcomes.</s><s xml:id="_paPdRsJ">Automated outcome data from the EHR for this health system and other health systems (Care Everywhere) was complemented by manual medical record review, which included any information inputted from other health systems or patient-supplied documents scanned into the record.</s><s xml:id="_s8rVfcf">Household income was estimated using American Community Survey 2017-2021 5-year estimate data for median income by zip code of residence.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4BN3F9R">Statistical Analysis</head><p xml:id="_UHu3PhU"><s xml:id="_eg7j73h">All power calculations identified increases that would justify health system investment in the different interventions.</s><s xml:id="_DGCVg2T">For trial A, we estimated a 7% response rate in the standard messaging arm (no bulk order, no text message) based on a prior pilot study (unpublished) and findings from other outreach activities. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b23">24</ref></s><s xml:id="_szNpW3e">e estimated 27 335 eligible patients, with 10% attrition for screening obtained outside the system or additional exclusions, resulting in 24 602 trial patients.</s><s xml:id="_uBxFjGq">For the bulk order comparison, an estimated 12 301 in each arm would provide 99% power to detect a 1.5-percentage point increase in response rate in the bulk order arm compared with the no bulk order arm using the χ 2 test of proportions, intention-to-treat protocol, and a 2-sided P &lt; .05 as statistically significant.</s><s xml:id="_w89Web7">In a prespecified subgroup analysis, we analyzed patients who self-reported as Black, since there are known disparities in outcomes in this patient population.</s><s xml:id="_a3n9QKJ">We anticipated a baseline response rate of 7% among Black patients.</s><s xml:id="_vEDJaAy">With 6944 Black patients in the trial (after 10% attrition), we estimated 87% power to detect a 2-percentage point increase in the bulk order arm.</s></p><p xml:id="_5H4ugTr"><s xml:id="_5qdeQGx">For the text messaging comparison in trial A, we estimated a 10% response rate in the no text messaging arm.</s><s xml:id="_QD6UrWS">The eligible population of 24 602 would provide approximately 97% power to detect an increase in response rate of 1.5 percentage points in the text messaging arm.</s><s xml:id="_rC9tuEk">We did not anticipate an interaction between bulk ordering and text messaging.</s><s xml:id="_Cqd3d2t">In a subgroup analysis of Black patients, we anticipated a baseline response rate of 10%.</s><s xml:id="_uDNvVQ2">With 6944 Black patients in the trial, we estimated 98% power to detect a 3-percentage point increase in the response rate in the text messaging arm.</s></p><p xml:id="_kr4Aa8e"><s xml:id="_7XwKpQB">For trial B, we estimated a 5% response rate in the standard messaging arm (no clinician endorsement, no text message).</s><s xml:id="_ZVKqPdF">We estimated 8482 eligible patients, with 10% attrition for screening obtained outside the system or additional exclusions, resulting in 7634 trial patients.</s><s xml:id="_Axr9z7s">For the clinician endorsement comparison, this estimate provided 96% power to detect a 2-percentage point increase in the clinician endorsement arm compared with the standard messaging arm.</s></p><p xml:id="_DS3zdjN"><s xml:id="_335UAZC">For the text messaging comparison in trial B, we estimated a 6% response rate in the no text messaging arm.</s><s xml:id="_r6YDrVK">The estimated eligible population of 7634 would provide approximately 93% power to detect an increase in response rate of 2 percentage points in the text messaging arm compared with no text messaging.</s><s xml:id="_GpVDNFU">We did not anticipate an interaction between clinician endorsement and text messaging.</s></p><p xml:id="_mUyBr4a"><s xml:id="_gZbUGkP">For the main comparisons (bulk ordering and text messaging in trial A and clinician endorsement and text messaging in trial B), we used the χ 2 test for 2 proportions to calculate the difference in response rate and the 95% CI, along with a 2-sided P &lt; .05 as statistically significant.</s><s xml:id="_dAhvZkF">Our hypotheses were that bulk ordering, text messaging, and clinician endorsement would increase response rates.</s><s xml:id="_4eCK6ta">We conducted similar analyses for the secondary outcome of mammogram completion at 6 months.</s><s xml:id="_Zet7dPy">We also performed subgroup analyses for the primary outcome using multivariable logistic models with treatment arm, age, race, ethnicity, income, patient portal status, and 1 treatment-bycovariate interaction at a time.</s><s xml:id="_nJYY94F">We conducted likelihood ratio tests to examine significance of the interaction term in each model.</s><s xml:id="_Gxakmmw">We report the estimated log odds ratio along with the 95% CI for each interaction, which quantifies the differential effect of treatment between subgroups (relative to a reference group for categorical covariates), adjusting for all other covariates in the model.</s><s xml:id="_9Tq8nQd">We also conducted a pooled analysis for text messaging response rate across both trials, adjusting for primary care region (region A vs region B).</s><s xml:id="_AP9KbDq">All analyses were performed using Stata, version 16.0 software (Stata Corp LP).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dmVnA7Z">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jSgHY6z">Participants</head><p xml:id="_gHmaqVv"><s xml:id="_GEmQuCe">A total of 24 680 patients were randomized across the 2 trials (18 453 patients in trial A and 6227 in trial B).</s><s xml:id="_UF5kQ26">A total of 48 patients across both trials were excluded from the analysis (41 patients from trial A and 7 from trial B).</s><s xml:id="_WUsAZrk">A total of 18 412 patients were included in the analysis of trial A (Figure <ref type="figure" target="#fig_0">1</ref>) and 6220 in trial B (Figure <ref type="figure" target="#fig_1">2</ref>).</s><s xml:id="_tpENVhd">The mean (SD) age was 60.4 (7.5) years; 62.4% had commercial insurance, 6.3% were insured by Medicaid, and 28.9% were insured by Medicare; 4.9% were Asian or Pacific Islander, 22.3% were Black, 3.6% were Hispanic or Latino, 65.7% were White, 7.1% were of other or unknown race, and 3.5% were of other or unknown ethnicity; and 76.0% were active electronic patient portal users (Table <ref type="table" target="#tab_2">1</ref>).</s><s xml:id="_dUWTYPb">Each patient was followed up for a total of 6 months.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tykWWpt">Mammogram Completion at 3 Months</head><p xml:id="_epg7SqS"><s xml:id="_tQHfwTd">In trial A, at 3 months, 15.4% (95% CI, 14.6%-16.1%) of patients completed a mammogram in the bulk order arm compared with 12.7% (95% CI, 12.1%-13.4%)</s><s xml:id="_jadpxr4">in the no order arm.</s><s xml:id="_JSsRymJ">In the text messaging comparison arms, 15.1% (95% CI, 14.3%-15.8%) of patients receiving text messaging completed a mammogram compared with 13.0% (95% CI, 12.4%-13.7%)</s><s xml:id="_TKcScR8">in the no text messaging arm.</s><s xml:id="_WCAdSdP">There was a significant increase in the mammogram completion rate in the bulk order arm compared with the no order arm (absolute difference, 2.7%; 95% CI, 1.6%-3.6%;</s><s xml:id="_jgZJYhk">P &lt; .001),</s><s xml:id="_rEdFb7Y">as well as a significant increase in the text messaging arm compared with the no text messaging arm (absolute difference, 2.1%; 95% CI, 1.0%-3.0%;</s><s xml:id="_Y77X65F">P &lt; .001)</s><s xml:id="_7KqX6xB">(Table <ref type="table">2</ref>).</s></p><p xml:id="_dBepHXD"><s xml:id="_HVHx6sw">At 3 months among Black patients in trial A, 12.6% (95% CI, 11.3%-13.9%) in the bulk order arm completed a mammogram compared with 9.9% (95% CI, 8.8%-11.1%) in the no order arm (absolute difference, 2.7%; 95% CI, 1.0%-4.5%;</s><s xml:id="_NsyEVzE">P = .003).</s><s xml:id="_xpgQt7Y">There was no significant difference (-0.3%; 95% CI, -2.0% to 1.5%;  <ref type="table">3</ref>).</s></p><p xml:id="_j59N8FZ"><s xml:id="_utUucs6">In trial B, at 3 months, 12.5% (95% CI, 11.3%-13.7%) of patients in the clinician endorsement arm completed a mammogram compared with 11.4% (95% CI, 10.3%-12.5%) in the standard messaging arm.</s><s xml:id="_YUpqWDj">In the text messaging comparison arms, 13.2% (95% CI, 12.0%-14.4%) of patients receiving text messaging completed a mammogram compared with 10.7% (95% CI, 9.7%-11.8%) in the no text messaging arm.</s><s xml:id="_yJE99Bd">There was no significant difference in mammogram completion from clinician endorsement (absolute difference, 1.1%; 95% CI, -0.5% to 2.7%; P = .18),</s><s xml:id="_fgDtryv">but the clinician difference in mammogram completion between the text messaging arms and no text messaging arms was significant (absolute difference, 2.5%; 95% CI, 0.8%-4.0%;</s><s xml:id="_UdYBKSE">P = .003)</s><s xml:id="_dgwW4zD">(Table <ref type="table">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3R7JqZU">Scheduling at 3 and 6 Months</head><p xml:id="_583XEyr"><s xml:id="_q9CkmBH">As a secondary outcome, scheduling data tracked closely with the primary outcome of mammogram completion, with 13% to 15% of patients scheduling within 3 months and 26% to 28% scheduling within 6 months.</s><s xml:id="_h5CUG6H">Between 2.2% and 2.4% of patients scheduled an appointment outside the 6-month outcome window, and only 0.2% in each arm were no-shows or cancelled, with similar rates across arms (eTable 1 in Supplement 2).</s><s xml:id="_TtsSZFH">Scheduling data were only available for patients in trial A since most of the mammograms in trial B occurred outside of the health system.</s><s xml:id="_AFYGThU">absence of interaction, although there was less of a response among patients identifying as Black and those with Medicare (eFigure 3 and eTable 5 in Supplement 2).</s><s xml:id="_DYGVkss">In the pooled subgroup analysis for text messaging that adjusted for region, we found an odds ratio of 1.20 (95% CI, 1.12-1.29)</s><s xml:id="_vB9MXyd">for the text messaging arm (eFigure 3 in Supplement 2).</s></p><p xml:id="_vnxxGUB"><s xml:id="_wVVZZyY">When looking at prior mammogram orders placed in trial A, patients with a prior order had a 3.4-percentage point increase in completion from bulk orders, while those without a prior order had a 2.1-percentage point increase (eTable 6 in Supplement 2).</s><s xml:id="_HRkv9pQ">When dividing this group further by patient portal status, only active patient portal users showed a higher increase among those with a prior order (eTable 7 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jXkz8bR">Cost Analysis</head><p xml:id="_RMfWa5f"><s xml:id="_u3nJ6Bq">We conducted a post hoc cost analysis of the interventions from the perspective of the health system when scaled across the entire study population, including only effort and cost that would be used for implementation and not any activities solely performed for research purposes.</s><s xml:id="_5xuDwyg">The cost per patient screened was $5.09 for basic outreach, $7.69 for basic outreach with text messaging, $4.07 for basic outreach with bulk ordering, and $6.23 for basic outreach with text messaging and bulk ordering (eTables 8 and 9 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vrCFDpk">Discussion</head><p xml:id="_RKmg7rX"><s xml:id="_cmF59AQ">In these trials, we found that bulk ordering and text messaging significantly increased patient response to breast cancer screening outreach.</s><s xml:id="_mgZAcsy">There was a similar response to bulk ordering among women identifying as Black but no effect from an additional text message.</s><s xml:id="_9wjZYwQ">Additionally, we did not find a statistically significant effect when the outreach was signed by the primary care clinician.</s></p><p xml:id="_kYZ5Ntd"><s xml:id="_WgtXYwR">The bulk signed order resulted in a small but significant increase in response rate of 2.7 percentage points.</s><s xml:id="_jv88CEs">There may be a few reasons for this finding.</s><s xml:id="_pWkdsWQ">First, bulk ordering framed participation as opt-out, as participation was implied.</s><s xml:id="_RbwguVs">Second, bulk ordering reduced effort for both clinicians and patients, as it reduced the number of steps toward completing the mammogram.</s><s xml:id="_qVBKdHX">Third, for patients with an active patient portal, bulk ordering also initiated a ticket for online scheduling.</s></p><p xml:id="_c8GRFGh"><s xml:id="_6m7mTWU">These bulk order findings are consistent with literature on opt-out framing, but prior studies have shown larger effect sizes of 12 percentage points for influenza vaccination, <ref type="bibr" target="#b16">17</ref> 19 percentage points for mailed colorectal cancer screening, <ref type="bibr" target="#b14">15</ref> and 24 percentage points for hepatitis C screening. <ref type="bibr" target="#b17">18</ref></s><s xml:id="_QygTwFh">The majority of women across all arms in our study still did not undergo mammography during the trial time frame.</s><s xml:id="_mX4pcbS">Our modest finding may have resulted from the scheduling process, the need for a radiology procedure, and the ongoing COVID-19 pandemic.</s><s xml:id="_w8S4mvU">The influenza vaccination study was embedded in an onsite occupation health effort, colorectal cancer screening was a mailed home testing kit, and hepatitis C screening was a simple blood test.</s><s xml:id="_BccS8gA">A study of opt-out framing for breast cancer screening at a Veterans Affairs (VA) clinic did not show effectiveness, potentially due to the need to schedule outside of the VA system. <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref></s><s xml:id="_QKpwgMS">The findings of our study may be more similar to the VA study than to other preventive clinical areas, which focused on different behaviors.</s></p><p xml:id="_XTTWFsx"><s xml:id="_Nas6n3x">Adding text message nudges to the existing outreach messaging was associated with a 2.1-and 2.5-percentage point increase in trials A and B, respectively.</s><s xml:id="_WfBtSYb">The text message served as an additional nudge and allowed for bidirectional communication to respond if patients had already completed screening or if they needed additional support.</s><s xml:id="_GrHmtB6">Our findings are consistent with other text messaging studies for preventive health activities. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref></s><s xml:id="_czcbRSG">]<ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref> We did not find an increase in obtaining a mammogram from text messaging among Black women, which is surprising as qualitative studies have shown acceptability and potential in the use of text messaging in this population. <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32</ref></s><s xml:id="_wCS9zXv">n trial B, there was a 1.1-percentage point higher response to the clinician endorsement letter that was not statistically significant.</s><s xml:id="_WEsBQ7G">There are a few reasons that might explain this finding.</s><s xml:id="_P5NczQg">First, patients may already have believed that the outreach was sanctioned by the primary care clinician due to the patient portal or health system letterhead.</s><s xml:id="_AjeDPuz">Second, these electronically produced signatures may not have invoked the same trust as a document that was manually signed by the primary care clinician.</s><s xml:id="_NDCTNH8">Third, we only had power to detect an approximately 2-percentage point increase in response, so there may have been a smaller effect size, which aligns with prior research on language or messaging content. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b27">28</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QnYvB2s">Strengths and Limitations</head><p xml:id="_9bzjuMY"><s xml:id="_rnQr4Gn">A key strength of this trial was the prospective individual-level randomization and close partnership with clinical operations.</s><s xml:id="_2vgzshK">We used tools that are readily available to health systems, making the findings more scalable as part of routine practice.</s><s xml:id="_JgxQefz">As there are known disparities in breast cancer outcomes, we conducted a prespecified subgroup analysis among the large proportion of patients who self-identified as Black.</s></p><p xml:id="_VHTtus4"><s xml:id="_DkCACj3">There are also some limitations.</s><s xml:id="_s3PM2ez">The trial was a singlecenter study among mainly insured patients who reflected the demographics of the health system, but the primary care network included a wide range of practice types across a large region, and we conducted subgroup analyses by race and ethnicity and income.</s><s xml:id="_GRDRRWU">We were not able to evaluate the qualitative experiences of patients or the long-term effect on repeated breast cancer screening.</s><s xml:id="_RB5mZz8">In addition, we did not enroll as many patients as anticipated in the power calculations due to increases in screening through routine practice, better ascertainment of patients screened through health system efforts, and the decision to only include patients aged 40 to 49 years who had a shared decision-making discussion with their primary care clinician.</s><s xml:id="_pTyc4K7">However, we still had reasonable power to detect the differences we hypothesized.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UxkUfqg">Conclusions</head><p xml:id="_WSZwbpX"><s xml:id="_rzzt4TY">The findings of these 2 concurrent, pragmatic, randomized clinical trials show that large-scale campaigns can be enhanced using new insights from behavioral science and information technology.</s><s xml:id="_UMU4FeK">Future studies are needed to show how screening rates can be increased further and for repeated screening programs.</s></p><p xml:id="_ec24zFE"><s xml:id="_jzd3we4">Behavioral Interventions to Improve Breast Cancer Screening Outreach Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2024 Volume 184, Number 7</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_5E7qpV7"><s xml:id="_Bkkw8Gw">Figure 1.</s><s xml:id="_SvMsbQK">CONSORT Diagram for Trial A</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_d96FEyX"><s xml:id="_prbDume">Figure 2. CONSORT Diagram for Trial B</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_d684T8g"><s xml:id="_NYYQdXc">Patient Characteristics</s></p></div></figDesc><table><row><cell cols="5">Behavioral Interventions to Improve Breast Cancer Screening Outreach</cell><cell></cell><cell></cell><cell cols="3">Original Investigation Research</cell></row><row><cell></cell><cell cols="2">No. of patients (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Trial A</cell><cell></cell><cell></cell><cell></cell><cell>Trial B</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Clinician</cell><cell></cell><cell>Standard</cell><cell></cell></row><row><cell></cell><cell></cell><cell>No order</cell><cell></cell><cell>Bulk order</cell><cell></cell><cell>endorsement</cell><cell></cell><cell>messaging</cell><cell></cell></row><row><cell></cell><cell></cell><cell>and text</cell><cell></cell><cell>and text</cell><cell>Clinician</cell><cell>and text</cell><cell>Standard</cell><cell>and text</cell><cell></cell></row><row><cell></cell><cell>No order</cell><cell>messaging</cell><cell>Bulk order</cell><cell>messaging</cell><cell>endorsement</cell><cell>messaging</cell><cell>messaging</cell><cell>messaging</cell><cell></cell></row><row><cell>Characteristic</cell><cell>(A1)</cell><cell>(A2)</cell><cell>(A3)</cell><cell>(A4)</cell><cell>(B1)</cell><cell>(B2)</cell><cell>(B3)</cell><cell>(B4)</cell><cell>Total</cell></row><row><cell>No. of patients</cell><cell>4608</cell><cell>4597</cell><cell>4602</cell><cell>4605</cell><cell>1553</cell><cell>1556</cell><cell>1556</cell><cell>1555</cell><cell>24 632</cell></row><row><cell>Age, mean (SD), y</cell><cell cols="5">60.4 (7.4) 60.4 (7.5) 60.6 (7.5) 60.4 (7.6) 60.6 (7.6)</cell><cell>60.0 (7.5)</cell><cell>60.3 (7.5)</cell><cell>60.1 (7.4)</cell><cell>60.4 (7.5)</cell></row><row><cell>Age group, y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>40-49</cell><cell>157 (3.4)</cell><cell>163 (3.6)</cell><cell>178 (3.9)</cell><cell>173 (3.8)</cell><cell>61 (3.9)</cell><cell>75 (4.8)</cell><cell>70 (4.5)</cell><cell>61 (3.9)</cell><cell>938 (3.8)</cell></row><row><cell>50-59</cell><cell>1999</cell><cell>1993</cell><cell>1958</cell><cell>1990</cell><cell>664</cell><cell>685</cell><cell>665</cell><cell>676</cell><cell>10 630</cell></row><row><cell></cell><cell>(43.4)</cell><cell>(43.4)</cell><cell>(42.6)</cell><cell>(43.2)</cell><cell>(42.8)</cell><cell>(44.0)</cell><cell>(42.7)</cell><cell>(43.5)</cell><cell>(43.2)</cell></row><row><cell>60-69</cell><cell>1785</cell><cell>1755</cell><cell>1766</cell><cell>1750</cell><cell>582</cell><cell>586</cell><cell>605</cell><cell>621</cell><cell>9450</cell></row><row><cell></cell><cell>(38.7)</cell><cell>(38.2)</cell><cell>(38.4)</cell><cell>(38.0)</cell><cell>(37.5)</cell><cell>(37.7)</cell><cell>(38.9)</cell><cell>(39.9)</cell><cell>(38.4)</cell></row><row><cell>70-74</cell><cell cols="5">667 (14.5) 686 (14.9) 700 (15.2) 692 (15.0) 246 (15.8)</cell><cell>210 (13.5)</cell><cell>216 (13.9)</cell><cell>197 (12.7)</cell><cell>3614 (14.7)</cell></row><row><cell>Race</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Asian or</cell><cell>170 (3.7)</cell><cell>190 (4.1)</cell><cell>193 (4.2)</cell><cell>180 (3.9)</cell><cell>117 (7.5)</cell><cell>128 (8.2)</cell><cell>113 (7.3)</cell><cell>120 (7.7)</cell><cell>1211 (4.9)</cell></row><row><cell>Pacific Islander</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Black</cell><cell>1275</cell><cell>1181</cell><cell>1250</cell><cell>1273</cell><cell>127</cell><cell>128</cell><cell>122</cell><cell>130</cell><cell>5486</cell></row><row><cell></cell><cell>(27.7)</cell><cell>(25.7)</cell><cell>(27.2)</cell><cell>(27.6)</cell><cell>(8.2)</cell><cell>(8.2)</cell><cell>(7.8)</cell><cell>(8.4)</cell><cell>(22.3)</cell></row><row><cell>White</cell><cell>2889</cell><cell>2940</cell><cell>2898</cell><cell>2892</cell><cell>1133</cell><cell>1132</cell><cell>1144</cell><cell>1148</cell><cell>16 176</cell></row><row><cell></cell><cell>(62.7)</cell><cell>(64.0)</cell><cell>(63.0)</cell><cell>(62.8)</cell><cell>(73.0)</cell><cell>(72.8)</cell><cell>(73.5)</cell><cell>(73.8)</cell><cell>(65.7)</cell></row><row><cell>Other or unknown a</cell><cell>274 (6.0)</cell><cell>286 (6.2)</cell><cell>261 (5.7)</cell><cell>260 (5.7)</cell><cell>176 (11.3)</cell><cell>168 (10.8)</cell><cell>177 (11.4)</cell><cell>157 (10.1)</cell><cell>1759 (7.1)</cell></row><row><cell>Ethnicity</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hispanic or Latino</cell><cell>138 (3.0)</cell><cell>143 (3.1)</cell><cell>157 (3.4)</cell><cell>120 (2.6)</cell><cell>97 (6.3)</cell><cell>78 (5.0)</cell><cell>83 (5.3)</cell><cell>79 (5.1)</cell><cell>895 (3.6)</cell></row><row><cell>Not Hispanic</cell><cell>4399</cell><cell>4380</cell><cell>4365</cell><cell>4403</cell><cell>1305</cell><cell>1345</cell><cell>1331</cell><cell>1343</cell><cell>22 871</cell></row><row><cell>or Latino</cell><cell>(95.5)</cell><cell>(95.3)</cell><cell>(94.9)</cell><cell>(95.6)</cell><cell>(84.0)</cell><cell>(86.4)</cell><cell>(85.5)</cell><cell>(86.4)</cell><cell>(92.9)</cell></row><row><cell>Other or unknown b</cell><cell>71 (1.5)</cell><cell>74 (1.6)</cell><cell>80 (1.7)</cell><cell>82 (1.8)</cell><cell>151 (9.7)</cell><cell>133 (8.6)</cell><cell>142 (9.1)</cell><cell>133 (8.6)</cell><cell>866 (3.5)</cell></row><row><cell>BMI, median (IQR) c</cell><cell>28.1</cell><cell>28.6</cell><cell>28.7</cell><cell>28.4</cell><cell>27.6</cell><cell>27.4</cell><cell>27.6</cell><cell>27.4</cell><cell>28.2</cell></row><row><cell></cell><cell>(24.0-33.7)</cell><cell>(24.1-34.2)</cell><cell>(24.1-34.3)</cell><cell>(25.0-34.0)</cell><cell>(23.6-32.2)</cell><cell>(23.4-32.3)</cell><cell>(23.6-32.8)</cell><cell>(23.9-32.1)</cell><cell>(23.9-33.6)</cell></row><row><cell cols="2">History of breast cancer 169 (3.7)</cell><cell>186 (4.1)</cell><cell>167 (3.6)</cell><cell>175 (3.8)</cell><cell>55 (3.5)</cell><cell>70 (4.5)</cell><cell>63 (4.1)</cell><cell>72 (4.6)</cell><cell>957 (3.9)</cell></row><row><cell>Family history</cell><cell cols="5">536 (11.6) 514 (11.2) 516 (11.2) 521 (11.3) 128 (8.2)</cell><cell>133 (8.6)</cell><cell>138 (8.9)</cell><cell>132 (8.5)</cell><cell>2618 (10.6)</cell></row><row><cell>of breast cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Prior screening</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Within 2 y</cell><cell cols="5">617 (13.4) 650 (14.1) 625 (13.6) 673 (14.6) 312 (20.1)</cell><cell>304 (19.5)</cell><cell>294 (18.9)</cell><cell>294 (18.9)</cell><cell>3769 (15.3)</cell></row><row><cell>Between 2 and 3 y</cell><cell>1217</cell><cell>1298</cell><cell>1235</cell><cell>1210</cell><cell>261</cell><cell>250</cell><cell>279</cell><cell>287</cell><cell>6037</cell></row><row><cell></cell><cell>(26.4)</cell><cell>(28.2)</cell><cell>(26.8)</cell><cell>(26.3)</cell><cell>(16.8)</cell><cell>(16.1)</cell><cell>(17.9)</cell><cell>(18.5)</cell><cell>(24.5)</cell></row><row><cell>&gt;3 y or No screening</cell><cell>2774</cell><cell>2649</cell><cell>2742</cell><cell>2722</cell><cell>980</cell><cell>1002</cell><cell>983</cell><cell>974</cell><cell>14 826</cell></row><row><cell>history</cell><cell>(60.2)</cell><cell>(57.6)</cell><cell>(59.6)</cell><cell>(59.1)</cell><cell>(63.1)</cell><cell>(64.4)</cell><cell>(63.2)</cell><cell>(62.6)</cell><cell>(60.2)</cell></row><row><cell>Patient portal status</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Active</cell><cell>3785</cell><cell>3778</cell><cell>3780</cell><cell>3782</cell><cell>896</cell><cell>896</cell><cell>897</cell><cell>895</cell><cell>18 709</cell></row><row><cell></cell><cell>(82.1)</cell><cell>(82.2)</cell><cell>(82.1)</cell><cell>(82.1)</cell><cell>(57.7)</cell><cell>(57.6)</cell><cell>(57.7)</cell><cell>(57.6)</cell><cell>(76.0)</cell></row><row><cell>Not active</cell><cell cols="5">823 (17.9) 819 (17.8) 822 (17.9) 823 (17.9) 657 (42.3)</cell><cell>660 (42.4)</cell><cell>659 (42.4)</cell><cell>660 (42.4)</cell><cell>5923 (24.0)</cell></row><row><cell>Insurance coverage</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Commercial</cell><cell>2756</cell><cell>2788</cell><cell>2698</cell><cell>2749</cell><cell>1075</cell><cell>1124</cell><cell>1078</cell><cell>1095</cell><cell>15 363</cell></row><row><cell></cell><cell>(59.8)</cell><cell>(60.7)</cell><cell>(58.6)</cell><cell>(59.7)</cell><cell>(69.2)</cell><cell>(72.2)</cell><cell>(69.3)</cell><cell>(70.4)</cell><cell>(62.4)</cell></row><row><cell>Medicaid</cell><cell>385 (8.4)</cell><cell>392 (8.5)</cell><cell>382 (8.3)</cell><cell>378 (8.2)</cell><cell>6 (0.4)</cell><cell>6 (0.4)</cell><cell>8 (0.5)</cell><cell>4 (0.3)</cell><cell>1561 (6.3)</cell></row><row><cell>Medicare</cell><cell>1370</cell><cell>1342</cell><cell>1426</cell><cell>1393</cell><cell>415</cell><cell>376</cell><cell>408</cell><cell>392</cell><cell>7122</cell></row><row><cell></cell><cell>(29.7)</cell><cell>(29.2)</cell><cell>(31.0)</cell><cell>(30.3)</cell><cell>(26.7)</cell><cell>(24.2)</cell><cell>(26.2)</cell><cell>(25.2)</cell><cell>(28.9)</cell></row><row><cell>Other or unknown</cell><cell>97 (2.1)</cell><cell>75 (1.6)</cell><cell>96 (2.1)</cell><cell>85 (1.9)</cell><cell>57 (3.7)</cell><cell>50 (3.2)</cell><cell>62 (4.0)</cell><cell>64 (4.1)</cell><cell>586 (2.4)</cell></row><row><cell>Household income,</cell><cell>85 722</cell><cell>85 722</cell><cell>85 248</cell><cell>85 291</cell><cell>103 427</cell><cell>104 227</cell><cell>104 227</cell><cell>104 227</cell><cell>95 707</cell></row><row><cell>median (IQR), $ d,e</cell><cell>(54 391-</cell><cell>(54 935-</cell><cell>(54 935-</cell><cell>(54 485-</cell><cell>(95 707-</cell><cell>(93 337-</cell><cell>(95 707-</cell><cell>(93 395-</cell><cell>(65 720-</cell></row><row><cell></cell><cell>106 738)</cell><cell>106 738)</cell><cell>106 738)</cell><cell>106 667)</cell><cell>137 347)</cell><cell>137 347)</cell><cell>137 347)</cell><cell>137 347)</cell><cell>110 452)</cell></row><row><cell cols="5">Abbreviation: BMI, body mass index (calculated as weight in kilograms divided</cell><cell cols="5">c BMI &lt;10 and &gt;100 removed (n = 3). Patient BMI within 2 years of the study</cell></row><row><cell cols="2">by height in meters squared).</cell><cell></cell><cell></cell><cell></cell><cell cols="3">start date was obtained from medical records.</cell><cell></cell><cell></cell></row><row><cell cols="5">a Includes patients who identified as American Indian or Alaska Native, patients</cell><cell cols="5">d American Community Survey (2017-2021) median household income in 2021</cell></row><row><cell cols="5">who identified as other race, patients who refused to disclose race, and</cell><cell cols="2">inflated dollars.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">patients with missing race.</cell><cell></cell><cell></cell><cell></cell><cell cols="3">e A total of 154 patients had missing income data.</cell><cell></cell><cell></cell></row><row><cell cols="5">b Includes patients who identified as other ethnicity, patients who refused to</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">disclose ethnicity, and patients with missing ethnicity.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_h5pZpHz"><p><s xml:id="_MZyKQ8T">jamainternalmedicine.com (Reprinted) JAMA Internal Medicine July 2024 Volume 184, Number 7 P = .76)</s><s xml:id="_F4MFHWU">in completion among Black patients in the text messaging arm (11.2%; 95% CI, 9.9%-12.4%)</s><s xml:id="_RWt8huN">compared with the no text messaging arm (11.4%; 95% CI, 10.2%-12.7%)</s><s xml:id="_wzCqXc7">(Table</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_BNrtaT8"><s xml:id="_FzY3Xge">JAMA Internal Medicine July 2024 Volume 184, Number 7 (Reprinted) jamainternalmedicine.com © 2024 American Medical Association.</s><s xml:id="_hEuPWeB">All rights reserved.</s><s xml:id="_QDbTGwA">Downloaded from jamanetwork.com</s><s xml:id="_xCpEMxE">by University of Iowa user on 07/28/2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_aU6DVVT"><s xml:id="_2MaTuTD">© 2024 American Medical Association.</s><s xml:id="_EGjg5cD">All rights reserved.</s><s xml:id="_YjXYdnc">Downloaded from jamanetwork.com</s><s xml:id="_xGXEr7y">by University of Iowa user on 07/28/2025</s></p></note>
		</body>
		<back>

			<div type="funding">
<div xml:id="_JbgPyWH"><p xml:id="_zmK7nDs"><s xml:id="_ptRkjyq">work.</s><s xml:id="_4BabzTX"><rs type="person">Dr Linn</rs> reported receiving personal fees from submitted work.</s><s xml:id="_ZCGQV7E">No other disclosures were reported.</s><s xml:id="_fRPkGA9">Funding/Support: This trial was supported by the <rs type="funder">University of Pennsylvania Health System</rs> and <rs type="funder">Marc J. Leder Cancer Innovation Fund</rs> at the <rs type="funder">Abramson Cancer Center</rs> and by grant <rs type="grantNumber">K08CA234326</rs> from the <rs type="funder">National Cancer Institute of the National Institutes of Health</rs> (<rs type="person">Dr Mehta</rs>).</s></p></div>
<div><head xml:id="_GxB32nJ">Role of the Funder/Sponsor:</head><p xml:id="_zZGHYsy"><s xml:id="_QJcdZQs">The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_K3VwsW8">
					<idno type="grant-number">K08CA234326</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HT5DNSy">Mammography Follow-Up and Outcomes</head><p xml:id="_sXsY5Bf"><s xml:id="_EFX9TVy">At 6 months, a total of 5714 patients completed mammograms across both trials.</s><s xml:id="_MJbjb7c">Of those, 604 patients (10.6%) were called back for additional mammographic evaluation after an abnormal examination, and 184 (3.2%) underwent a biopsy.</s><s xml:id="_7XXHFHZ">Seventy-six patients (1.3%) who completed a mammogram were diagnosed with breast cancer, most (54 of 76 [71.1%]) with early-stage breast cancer (stage 0 or I).</s><s xml:id="_HQfRqCq">All patients (100%) diagnosed with cancer were referred and had started treatment (eTable 2 in Supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_g8FA9ZM">Subgroup Analyses</head><p xml:id="_gJ9gdhS"><s xml:id="_czYXtwZ">We conducted a subgroup analysis for the primary outcome and found no significant differences by trial arm for bulk ordering (eFigure 1 and eTable 3 in Supplement 2) and clinician endorsement (eFigure 2 and eTable 4 in Supplement 2).</s><s xml:id="_TPfc3rg">We did not find any interaction between the bulk order and text messaging arms in trial A or clinician endorsement and text messaging arms in trial B. Additionally, a pooled subgroup analysis of text message response rate across both trials had a similar</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_Nmb3Spn">Breast cancer statistics</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Giaquinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21754</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XMxUeB7">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="524" to="541" />
			<date type="published" when="2022">2022. 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72 (6):524-541. doi:10.3322/caac.21754</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_d4hbmUR">The benefits and harms of breast cancer screening: an independent review</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>Independent</surname></persName>
		</author>
		<author>
			<persName><surname>Panel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cancer</forename><surname>Breast</surname></persName>
		</author>
		<author>
			<persName><surname>Screening</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(12)61611-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sn6Hu7J">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="1778" to="1786" />
			<date type="published" when="2012">2012. 9855</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012; 380(9855):1778-1786. doi:10.1016/S0140-6736(12) 61611-0</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_Bhgcy8y">Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Oeffinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eth</forename><surname>Fontham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Etzioni</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.12783?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a2Fj5gZ">JAMA</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1599" to="1614" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Oeffinger KC, Fontham ETH, Etzioni R, et al; American Cancer Society. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314 (15):1599-1614. doi:10.1001/jama.2015.12783</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_mwvfSSy">Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement</title>
		<author>
			<orgName type="collaboration">US Preventive Services Task Force</orgName>
		</author>
		<idno type="DOI">10.7326/0003-4819-151-10-200911170-00008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2kbEmM4">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="716" to="726" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726, W-236. doi:10.7326/0003- 4819-151-10-200911170-00008</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main" xml:id="_NbYqDAx">Breast cancer screening</title>
		<idno type="DOI">10.32388/as69sd</idno>
		<ptr target="https://progressreport.cancer.gov/detection/breast_cancer#field_healthy_people_2020_target" />
		<imprint>
			<date type="published" when="2023-11-09">2023. November 9, 2023</date>
		</imprint>
		<respStmt>
			<orgName>National Cancer Institute</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Breast cancer screening. National Cancer Institute; 2023. Accessed November 9, 2023. https://progressreport.cancer.gov/detection/ breast_cancer#field_healthy_people_2020_target</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ET2A9Bj">Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Oakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Patton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jain</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamaoncol.2022.5481?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XxjpH9t">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="145" to="146" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Oakes AH, Boyce K, Patton C, Jain S. Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic. JAMA Oncol. 2023;9 (1):145-146. doi:10.1001/jamaoncol.2022.5481</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_zgtXkSp">Effect of direct mail as a population-based strategy to increase mammography use among low-income underinsured women ages 40 to 64 years</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Slater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Henly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Ha</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-05-0034</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ydV332x">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2346" to="2352" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Slater JS, Henly GA, Ha CN, et al. Effect of direct mail as a population-based strategy to increase mammography use among low-income underinsured women ages 40 to 64 years. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2346-2352. doi:10.1158/1055-9965.EPI-05-0034</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_52trHhp">A 4-year randomized trial comparing three outreach interventions to promote screening mammograms</title>
		<author>
			<persName><forename type="first">R</forename><surname>Luckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Costanza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>White</surname></persName>
		</author>
		<idno type="DOI">10.1093/tbm/iby031</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zXPZzaG">Transl Behav Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="328" to="335" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Luckmann R, Costanza ME, White MJ, et al. A 4-year randomized trial comparing three outreach interventions to promote screening mammograms. Transl Behav Med. 2019;9(2): 328-335. doi:10.1093/tbm/iby031</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_BZxYjmr">Effect of a multimodal reminder program on repeat mammogram screening</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Feldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Rosales</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2009.03.022</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bWwEuht">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="94" to="101" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Feldstein AC, Perrin N, Rosales AG, et al. Effect of a multimodal reminder program on repeat mammogram screening. Am J Prev Med. 2009;37 (2):94-101. doi:10.1016/j.amepre.2009.03.022</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_b6Rm5Uw">Mailed letter versus phone call to increase uptake of cancer screening: a pragmatic, randomized trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kiran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Davie</forename><forename type="middle">S</forename><surname>Moineddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lofters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.3122/jabfm.2018.06.170369</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hfEuT3y">J Am Board Fam Med</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="857" to="868" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kiran T, Davie S, Moineddin R, Lofters A. Mailed letter versus phone call to increase uptake of cancer screening: a pragmatic, randomized trial. J Am Board Fam Med. 2018;31(6):857-868. doi:10.3122/jabfm.2018.06.170369</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_2TySatf">Prospect theory: an analysis of decision under risk</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tversky</surname></persName>
		</author>
		<idno type="DOI">10.2307/1914185</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EUdS5tR">Econometrica</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="263" to="291" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979; 47(2):263-291. doi:10.2307/1914185</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_BRmEbUm">Judgment under uncertainty: heuristics and biases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tversky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.185.4157.1124</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jVYPMeV">Science</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">4157</biblScope>
			<biblScope unit="page" from="1124" to="1131" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185 (4157):1124-1131. doi:10.1126/science.185.4157.1124</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_VtDvVnM">Status quo bias in decision making</title>
		<author>
			<persName><forename type="first">W</forename><surname>Samuelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zeckhauser</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00055564</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WYRgUVg">J Risk Uncertain</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="7" to="59" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertain. 1988;1(1):7-59. doi:10.1007/BF00055564</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_TYPe8nZ">Harnessing the power of default options to improve health care</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Halpern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Ubel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmsb071595</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GeGSXvB">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1340" to="1344" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. N Engl J Med. 2007;357(13):1340-1344. doi:10.1056/NEJMsb071595</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_asutDPz">A randomized controlled trial of opt-in versus opt-out colorectal cancer screening outreach</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerra</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41395-018-0151-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R5Ga4gW">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1848" to="1854" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehta SJ, Khan T, Guerra C, et al. A randomized controlled trial of opt-in versus opt-out colorectal cancer screening outreach. Am J Gastroenterol. 2018;113(12):1848-1854. doi:10.1038/s41395-018- 0151-3</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_rTSkstH">Text messaging and opt-out mailed outreach in colorectal cancer screening: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Huf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Reitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-020-06415-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QaTuB6P">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1958" to="1964" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Huf SW, Asch DA, Volpp KG, Reitz C, Mehta SJ. Text messaging and opt-out mailed outreach in colorectal cancer screening: a randomized clinical trial. J Gen Intern Med. 2021;36(7):1958-1964. doi:10.1007/s11606-020-06415-8</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_gxrS3tg">Opting in vs opting out of influenza vaccination</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Colby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoon</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2010.892?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6RKkgUm">JAMA</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="44" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chapman GB, Li M, Colby H, Yoon H. Opting in vs opting out of influenza vaccination. JAMA. 2010; 304(1):43-44. doi:10.1001/jama.2010.892</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_SNK7a7U">Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Day</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Norris</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.n1022</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_af7UXRY">BMJ</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page">1022</biblScope>
			<date type="published" when="1022">2021. 1022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehta SJ, Day SC, Norris AH, et al. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial. BMJ. 2021;373(1022):n1022. doi:10.1136/bmj.n1022</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_7uqxk6j">Social influence: social norms, conformity and compliance</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Cialdini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Trost</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470561119</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_kRKRzjG">The Handbook of Social Psychology</title>
		<editor>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Gilbert</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Fiske</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><surname>Lindzey</surname></persName>
		</editor>
		<imprint>
			<publisher>McGraw-Hill</publisher>
			<date type="published" when="1998">1998</date>
			<biblScope unit="page" from="151" to="192" />
		</imprint>
	</monogr>
	<note>4th ed.</note>
	<note type="raw_reference">Cialdini RB, Trost MR. Social influence: social norms, conformity and compliance. In: Gilbert DT, Fiske ST, Lindzey G, eds. The Handbook of Social Psychology. 4th ed. Vol 1-2. McGraw-Hill; 1998: 151-192.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_EvvpC9m">The interaction of descriptive and injunctive social norms in promoting energy conservation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bonan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cattaneo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Adda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tavoni</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41560-020-00719-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MDJTTdJ">Nat Energy</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="900" to="909" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bonan J, Cattaneo C, d&apos;Adda G, Tavoni M. The interaction of descriptive and injunctive social norms in promoting energy conservation. Nat Energy. 2020;5(11):900-909. doi:10.1038/s41560-020- 00719-z</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_uS45MYz">Effect of text messaging and behavioral interventions on COVID-19 vaccination uptake: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mallozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Shaw</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2022.16649?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9c9k2Fr">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">2216649</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehta SJ, Mallozzi C, Shaw PA, et al. Effect of text messaging and behavioral interventions on COVID-19 vaccination uptake: a randomized clinical trial. JAMA Netw Open. 2022;5(6):e2216649. doi:10.1001/jamanetworkopen.2022.16649</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_bwaDBB8">Misdirections in informed consent-impediments to health care innovation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Ziolek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp1707991</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MCqVw7E">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">377</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1412" to="1414" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent-impediments to health care innovation. N Engl J Med. 2017;377(15):1412-1414. doi:10.1056/NEJMp1707991</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_YQ6u9SK">On the way to health</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fVFAHzy">LDI Issue Brief</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Volpp KG. On the way to health. LDI Issue Brief. 2012;17(9):1-4.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_AjYFPre">Effect of sequential or active choice for colorectal cancer screening outreach: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Induru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Santos</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2019.10305?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mjy56M2">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">1910305</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mehta SJ, Induru V, Santos D, et al. Effect of sequential or active choice for colorectal cancer screening outreach: a randomized clinical trial. JAMA Netw Open. 2019;2(8):e1910305. doi:10.1001/jamanetworkopen.2019.10305</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_enPxghk">Automated opt-out vs opt-in patient outreach strategies for breast cancer screening: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Marcotte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deeds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wheat</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2023.4321?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qCcfx3J">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1187" to="1194" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marcotte LM, Deeds S, Wheat C, et al. Automated opt-out vs opt-in patient outreach strategies for breast cancer screening: a randomized clinical trial. JAMA Intern Med. 2023; 183(11):1187-1194. doi:10.1001/jamainternmed.2023. 4321</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_U4fk7B7">Designing effective and appropriate opt-out approaches for patient outreach</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Waddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2023.4628?utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamainternmed.2024.0495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fR5jj7s">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1194" to="1195" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Waddell KJ, Mehta SJ. Designing effective and appropriate opt-out approaches for patient outreach. JAMA Intern Med. 2023;183(11):1194-1195. doi:10.1001/jamainternmed.2023.4628</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_r4hZFY6">Text messaging as a tool for behavior change in disease prevention and management</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cole-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kershaw</surname></persName>
		</author>
		<idno type="DOI">10.1093/epirev/mxq004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sr2zcdN">Epidemiol Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="69" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56-69. doi:10.1093/epirev/mxq004</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_gHP7wq2">A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor&apos;s appointment</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Milkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gandhi</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.2101165118</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9R6aKut">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page">2101165118</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Milkman KL, Patel MS, Gandhi L, et al. A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor&apos;s appointment. Proc Natl Acad Sci U S A. 2021;118 (20):e2101165118. doi:10.1073/pnas.2101165118</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_5nftcSu">Text messaging interventions on cancer screening rates: a systematic review</title>
		<author>
			<persName><forename type="first">C</forename><surname>Uy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trinh-Shevrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Sherman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Liang</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.7893</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4w6H5C9">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">296</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Uy C, Lopez J, Trinh-Shevrin C, Kwon SC, Sherman SE, Liang PS. Text messaging interventions on cancer screening rates: a systematic review. J Med Internet Res. 2017;19(8): e296. doi:10.2196/jmir.7893</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_wzyK6wF">Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Kerrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shukla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Oyebode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Friedman</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2015.36</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vcTFrNu">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1005" to="1010" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kerrison RS, Shukla H, Cunningham D, Oyebode O, Friedman E. Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population. Br J Cancer. 2015;112(6): 1005-1010. doi:10.1038/bjc.2015.36</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_E9exxNm">Text messaging as a communication modality to promote screening mammography in low-income African American women</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Ntiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Swanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Klyushnenkova</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10916-022-01814-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ReN7zDR">J Med Syst</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">28</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ntiri SO, Swanson M, Klyushnenkova EN. Text messaging as a communication modality to promote screening mammography in low-income African American women. J Med Syst. 2022;46(5): 28. doi:10.1007/s10916-022-01814-2</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_GSrpTUE">Using an integrated social-behavioral text message approach to improve screening mammography in African American women</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dhahri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nyanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ntiri</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.2020.38.29_suppl.240</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RrMKWYF">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page">240</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note>suppl</note>
	<note type="raw_reference">Dhahri A, Nyanin P, Ntiri S. Using an integrated social-behavioral text message approach to improve screening mammography in African American women. J Clin Oncol. 2020;38(29) (suppl):240. doi:10.1200/JCO.2020.38.29_suppl.240</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
